candesartan cilexetil has been researched along with tacrolimus in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Delabio, LC; Dutra, JP; Hembecker, M; Kita, DH; Moure, VR; Pereira, GDS; Scheiffer, G; Valdameri, G; Zattoni, IF | 1 |
| Hori, M; Mano, T; Masuyama, T; Miwa, T; Nishikawa, N; Ookawara, T; Sakata, Y; Sugawara, M; Suzuki, K; Yamaguchi, Y; Yamamoto, K; Yoshida, J | 1 |
| Birkel, M; Kiel, G; Philipp, T; Pietruck, F; Stahlheber-Dilg, B | 1 |
1 review(s) available for candesartan cilexetil and tacrolimus
| Article | Year |
|---|---|
Targeting breast cancer resistance protein (BCRP/ABCG2): Functional inhibitors and expression modulators.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; Breast Neoplasms; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Female; Humans; Neoplasm Proteins; Neoplastic Stem Cells | 2022 |
1 trial(s) available for candesartan cilexetil and tacrolimus
| Article | Year |
|---|---|
Evaluation of the effect of candesartan cilexetil on the steady-state pharmacokinetics of tacrolimus in renal transplant patients.
Topics: Administration, Oral; Adult; Antihypertensive Agents; Benzimidazoles; Biological Availability; Biphenyl Compounds; Blood Pressure; Creatinine; Drug Administration Schedule; Drug Interactions; Female; Graft Rejection; Humans; Hypertension; Immunosuppressive Agents; Kidney Transplantation; Male; Metabolic Clearance Rate; Middle Aged; Tacrolimus; Tetrazoles | 2005 |
2 other study(ies) available for candesartan cilexetil and tacrolimus
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Myocardial stiffness is determined by ventricular fibrosis, but not by compensatory or excessive hypertrophy in hypertensive heart.
Topics: Analysis of Variance; Angiotensin Receptor Antagonists; Animals; Benzimidazoles; Biphenyl Compounds; Calcineurin Inhibitors; Collagen Type I; Collagen Type III; Diastole; Fibrosis; Heart Ventricles; Hydroxyproline; Hypertension; Male; Myocardium; Rats; Rats, Inbred Dahl; RNA, Messenger; Tacrolimus; Tetrazoles; Ventricular Dysfunction, Left | 2002 |